Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
The science is clear, and the lives saved will be real
Naomi Loomis: Olympias investing in research and development on compounding other GLP-1s that may go on shortage or potential combination GLP-1s to have more accessible options, which will help keep patients on track with their weight loss and diabetes management
Non-GLP therapies may be considered for patients who: Are not candidates for GLP-1 medications Prefer non-injectable treatment options Have experienced side effects with other therapies Are seeking medically supervised weight management support A licensed clinician will determine the most appropriate treatment approach based on medical history, current conditions, and overall health goals
The survey found a quarter of the respondents taking GLP-1 medications were paying for the drugs which can cost hundreds of dollars a month completely out of pocket
US$ 23.43
US$ 22.15
US$ 28.01
US$ 29.23
US$ 23.87
US$ 29.56
US$ 25.86
US$ 22.84
